6H4-11904-81523
2 vaccinations
1 coded response
3 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 727 / AR
- Registered
- 2021-04-29
- Relationship
- Self
- Race
- Asian
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-28
Dose 1 — Pfizer-BioNTech
-
2021-04-29
Registered in v-safe
-
2021-04-29
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Nausea · Be unable to do your normal daily activitiesAdult check-in
-
2021-05-01
Survey response — days 1–6 daily, dose 1MedDRA: Blood glucose fluctuation — Feeling: Fair · Site: Pain · NauseaFree text: Sugar fluctuationsMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-19
Dose 2 — Pfizer-BioNTech
-
2021-05-20
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Fever · Joint pains, Muscle or body aches, Nausea · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-28 | Pfizer-BioNTech | |
| 2 | 2021-05-19 | Pfizer-BioNTech |
Free text
Release 8 — days 1–6 daily, dose 1
Systemic reaction (other): Sugar fluctuations
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Blood glucose fluctuation | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release